4174.0 Meth, Opiates, and Other Drugs

Tuesday, November 6, 2007: 2:30 PM
Poster

Board 1
Providing Buprenorphine treatment in HIV primary care settings: Lessons from the BHIVES collaborative
Linda Weiss, PhD, Julie Netherland, MSW, James Egan, MPH, David Fiellin, MD, Lois Eldred, DrPH, Bruce R. Schackman, PhD and Ruth Finkelstein, ScD
Board 2
A Longitudinal Analysis of Patterns of Ketamine Use among Young Injection Drug Users
Stephen E. Lankenau, PhD, Bill Sanders, PhD, Jennifer Jackson Bloom, MPH and Dodi Hathazi, BS
Board 3
Board 4
Providing Buprenorphine treatment in HIV care settings: Self-reported outcomes at 30 days
Linda Weiss, PhD, Michael Botsko, MSW, James Egan, MPH, Marc N. Gourevitch, MD, MPH, Frederick L. Altice, MD, P. Todd Korthuis, MD, Jennifer Mitty, MD, MPH, Lynn Sullivan, MD and David Fiellin, MD
Board 5
Tiking Teens: A Methamphetamine Epidemic in the Western Cape of South Africa among a Sample of Female School Drop-outs
Wendee M. Wechsberg, PhD, Winnie Luseno, MA, Kyla S. Kurian, PhD and Celeste Naidoo
Board 6
Startup challenges to implementing a naloxone distribution program
Sarah Bowman, MPH, Portia Thurmond, MPH, Beth Schwartzapfel, BA, Erin Argueta, BA, Michelle McKenzie, MPH and Josiah Rich, MD, MPH
Board 7
Board 9
Assisting opiate addicted offenders upon re-entry: 12 month outcomes for a methadone linkage program
Michelle McKenzie, MPH, Bradley Anderson, PhD, Portia Thurmond, MPH, Grace Macalino, PhD and Josiah Rich, MD, MPH
Board 10
Initiation to methamphetamine use among women in the U.S./Mexico border
Javier Lopez-Zetina, PhD, MA, Bridget Rogala, MPH(c), CHES and Ferrari Griarte, MS

See individual abstracts for presenting author's disclosure statement and author's information.

Organized by: Alcohol, Tobacco, and Other Drugs
Endorsed by: Women's Caucus, Epidemiology